跳至主要内容
临床试验/NCT04280354
NCT04280354终止不适用

Prospective Study to Discover New Biomarkers for Early Detection of Sepsis and Prediction of Sepsis-related Mortality in Patients With Severe Community Acquired Pneumonia (sCAP)

University Hospital, Basel, Switzerland15 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2022年2月16日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
15
主要终点
Detection of sepsis

研究概览

简要总结

This multi-center observational case-control study in Intensive Care Unit (ICU) patients is to identify novel biomarkers allowing to recognize severe community acquired pneumonia (sCAP) -associated sepsis at an earlier stage and predict sepsis-related mortality. Patients with sCAP (cases) will be profoundly characterized over time regarding the development of sepsis and compared with control patients. The mechanisms and influencing factors on the clinical course will be explored with most modern -omics technologies allowing a detailed characterisation. These data will be analysed using machine learning algorithms and multi-dimensional mathematical models.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission to the ICU of one of the participating centers.
  • Cases: severe community acquired pneumonia with requirement for ICU admission.
  • Controls: Clinical phenotype of inflammation not due to suspected sepsis In addition, control patients will be patients with fever >38°C, CRP >100mg/L, no infection focus expected in ≥ 24h.
  • All required sample types can most likely be collected within the first 24h visits.
  • Expected ICU stay of more than 24h.

排除标准

  • Admission to the hospital within the prior 14 days.
  • Patients with psychosis
  • Evidence of a hospital acquired pneumonia.
  • One of the following respiratory conditions: Acute exacerbation of chronic obstructive pulmonary disease (COPD) or bronchiectasis, acute severe asthma, aspiration pneumonia, tuberculosis, clinical suspected viral pneumonia without bacterial infection, cardiogenic pulmonary oedema.
  • Patients with an acute respiratory distress Syndrome (ARDS).
  • Patient which can be managed as outpatients and do not require an ICU.
  • Patient where a transmission to another institution is likely within the next 24h.
  • Documented rejection of the general consent or participation to research in general.
  • Patients with a palliative situation and a life expectancy due to other diseases (e.g. progressed cancer) less than 28 days.

结局指标

主要结局

Detection of sepsis

时间窗: within 7 days after study inclusion

Sepsis detection based on new discovered digital biomarkers will be compared to classical sepsis-3 criteria (with an increase of the sequential organ failure assessment (SOFA) score of 2 or larger score points).

Time to sepsis detection (minutes after Intensive Care Unit (ICU) admission)

时间窗: within 7 days after study inclusion

Time to sepsis detection (minutes after ICU admission) based on machine learning

Sepsis related mortality

时间窗: within 7 days after study inclusion

Prediction of sepsis related mortality (with \>80% sensitivity and specificity at least 24h prior to event)

次要结局

未报告次要终点

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验